CLINICAL_TRIALS
trial_result
· 2010-08-02
Clinical Trial Update: Safety and Efficacy of GW786034 (Pazopanib) In Metastatic Renal Cell Carcinoma [Phase 3]
Summary
Phase 3 trial evaluating pazopanib for metastatic renal cell carcinoma reports safety and efficacy results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GlaxoSmithKline | Conditions: Carcinoma, Renal Cell | Phase 3 | Status: COMPLETED | Results posted: 2010-08-02